Longevity funding: Function Health's $298M raise

The first trillion-dollar healthcare company, a $298M longevity round, and a telehealth CEO headed for federal sentencing. Last month had range.

Today on the show, Halle and Michael sort through the biggest December stories shaping the year ahead, from runaway longevity funding to a telehealth scandal headed for federal sentencing.

We cover:

🧬 Two hot funding rounds in longevity, including Function Health’s $298M B-round and Blueprint’s all-angel, no-VC $60M raise

💊 How Eli Lilly became the first trillion-dollar healthcare company

🏥 CVS’s $5.7B Oak Street Health write-down (and why most acquisitions fail)

🎓 Nursing, OT, PT, and PA being removed from the list of “professional” degrees by the Department of Education

🤖 OpenAI’s growing interest in consumer health tools

⚖️ The telehealth company whose founders were just convicted in one of the largest stimulant-fraud cases to date

—

Show notes:

• Eli Lilly becomes first trillion-dollar healthcare company (Reuters)
• CVS takes $5.7B goodwill impairment on Oak Street Health (Forbes)
• Department of Education’s revised “professional degree” list (Newsweek)
• NYT: Patients turning to AI for support (Dagens.com)
• DOJ conviction of Done Global executives (DOJ)

—

📍 Connect with us:

Heart of Healthcare website

LinkedIn

Instagram

Youtube

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.